-

Cutera, Inc. Appoints Brent Hauser as President, International

Hauser Brings Over 20 Years of Aesthetics Industry Experience in Markets Across the Globe

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Brent Hauser as President, International, effective October 2, 2023.

Mr. Hauser will report directly to Taylor Harris, Cutera’s Chief Executive Officer, and will be responsible for commercial performance in existing international markets, expansion into new geographies, and the international launch of AviClear, the company’s pioneering energy-based device for the treatment of mild to severe acne, in 2024. Mr. Hauser brings over 20 years of aesthetics industry experience in markets across the globe. Mr. Hauser and his family will be relocating to Australia in early 2024. Until that time, Mr. Hauser will work closely with the North American commercial leadership team to plan for and execute on a redesigned business model and go-to-market approach for AviClear in North America, both for existing and new customers.

Taylor Harris, Chief Executive Officer, said, “I am thrilled to welcome Brent to the Cutera team. During his two decades in the aesthetics industry, Brent has demonstrated tremendous leadership capability and commercial savvy in markets across the globe. And in our time working together at Zeltiq, I developed tremendous respect for Brent as an individual, one who demonstrates all of the leadership commitments and core values to which Cutera aspires, including a relentless focus on our customers. I look forward to his contributions as we seek to grow our international business and optimize the launch of AviClear both in North America and abroad.”

Mr. Hauser said, “We have a significant opportunity ahead of us at Cutera, as we seek to expand our presence in international markets and bring the exciting AviClear technology to customers outside of North America. I am honored to join and lead the international team, and to work with them to provide unmatched products and service to our customers.”

About Brent Hauser:
Mr. Hauser has over two decades of aesthetics industry experience in commercial roles of increasing responsibility. Mr. Hauser started his career in the laser aesthetics industry at Solta Medical, where he held sales leadership positions in both the European and Asia Pacific regions. Subsequently, Mr. Hauser joined Zeltiq, where he rose to the position of President, North American Operations, responsible for all commercial activity in North America. Following the acquisition of Zeltiq by Allergan, Mr. Hauser became Vice President of Sales and Marketing for the CoolSculpting brand on a global basis. For the last two years, Mr. Hauser has served as Senior Vice President of Global Sales for InBrace. Mr. Hauser holds a Bachelor’s Degree in Biology from Stanford University, where he was an All-American cross country runner, holding several school records. He currently serves on the board of directors of the Cure JM (juvenile myositis) Foundation.

About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

Contacts

Greg Barker
VP, Corporate FP&A and Investor Relations
415-657-5500
IR@cutera.com

Cutera, Inc.

NASDAQ:CUTR
Details
Headquarters: Brisbane, CA
CEO: Taylor Harris
Employees: 450
Organization: PUB
Revenues: $252 million (2022)
Net Income: NM (2022)

Release Versions

Contacts

Greg Barker
VP, Corporate FP&A and Investor Relations
415-657-5500
IR@cutera.com

More News From Cutera, Inc.

Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financ...

Cutera Announces Voluntarily Delisting from Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be...

Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that it is initiating a restructuring transaction with the support of a group of existing lenders, representing approximately 74% of the Company’s notes, to strengthen its balance sheet and position Cutera for long-term success. Through the transaction, Cutera will reduce its debt by nearly $400 million, or over 90%, and raise $65 million in ne...
Back to Newsroom